SELZENTRY (maraviroc) Patient Assistance Program
Don’t let the high cost of brand HIV entry inhibitor therapy disrupt your treatment. We help eligible patients access Selzentry (maraviroc) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Selzentry (maraviroc) is FDA-approved as a CCR5 co-receptor antagonist for the treatment of CCR5-tropic HIV-1 infection in adults and pediatric patients (≥2 years and ≥10 kg), used in combination with other antiretrovirals.
- Without assistance, Selzentry costs commonly run approximately $2,200–$2,600 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Selzentry for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Selzentry in the U.S. as of 2026. Selzentry requires tropism testing before use (only effective against CCR5-tropic HIV; ineffective against CXCR4-tropic or dual/mixed-tropic HIV). It is primarily used in treatment-experienced patients; not first-line for treatment-naïve patients.
What Is Selzentry Prescription Assistance Program?
The Selzentry Prescription Assistance Program is a manufacturer-sponsored initiative that provides Selzentry at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients with CCR5-tropic virus who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, tropism testing documentation, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Selzentry costs roughly $2,200–$2,600/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$2,550.00 | Save ~$2,480/mo |
| CVS Pharmacy | ~$2,600.00 | Save ~$2,530/mo |
| Walmart | ~$2,300.00 | Save ~$2,230/mo |
| Costco | ~$2,250.00 | Save ~$2,180/mo |
Kroger | ~$2,300.00 | Save ~$2,230/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Selzentry Prescription Program?
The Patient Assistance Program is free to apply for and provides Selzentry at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Selzentry:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $2,200–$2,600 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Selzentry assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Selzentry Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Selzentry:
Selzentry (maraviroc) is a twice-daily oral CCR5 co-receptor antagonist used as a component of HIV-1 antiretroviral therapy. It blocks HIV entry into CD4 T-cells by binding the CCR5 co-receptor that CCR5-tropic HIV uses to enter cells. It is primarily used in treatment-experienced patients with limited remaining options.
How Selzentry Works:
HIV-1 enters CD4 T-cells by utilizing the CD4 receptor alongside a co-receptor, which is typically either CCR5 or CXCR4. Maraviroc works by binding to the CCR5 receptor on the cell surface, preventing the virus’s gp120 protein from attaching and blocking entry. Because it only blocks CCR5-tropic strains, which make up about 80% of global infections, it has no effect on CXCR4-tropic or dual/mixed-tropic viruses. Consequently, patients must undergo tropism testing before starting the medication to ensure their specific virus strain is compatible with the treatment.
Form and use:
Selzentry is an oral medication taken twice daily, with or without food, but its specific dosing is highly dependent on co-administered antiretroviral therapies. The standard dose is 300 mg twice daily, but it must be decreased to 150 mg when combined with strong CYP3A inhibitors or increased to 600 mg when taken with strong CYP3A inducers. To ensure the medication will be effective, a tropism test is strictly required prior to initiating therapy to confirm the presence of CCR5-tropic HIV.
Generic availability:
As of 2026, there is no generic version of Selzentry available in the United States. Other specialized HIV entry inhibitors on the market include the injectable fusion inhibitor enfuvirtide, the intravenous post-attachment inhibitor ibalizumab, and the oral attachment inhibitor fostemsavir. Because of their specific mechanisms, these alternative entry inhibitors are typically reserved for treatment-experienced patients who have developed multi-drug resistance.
Warnings:
Selzentry carries a Boxed Warning for hepatotoxicity, which includes severe liver events that may be preceded by allergic features such as a rash, eosinophilia, or IgE elevation. Additional warnings include severe skin reactions like Stevens-Johnson syndrome, cardiovascular events such as postural hypotension and myocardial infarction, and the risk of immune reconstitution syndrome. Furthermore, patients face an increased risk of infections, including the reactivation of latent infections like tuberculosis, and significant drug interactions because maraviroc is a CYP3A substrate.
FAQ (Frequently Asked Questions)
How Much Does Selzentry Cost Without Insurance?
Selzentry costs approximately $2,200–$2,600 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Selzentry at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Do I Need Tropism Testing Before Selzentry?
Selzentry only works against CCR5-tropic HIV. It has no effect on CXCR4-tropic or dual/mixed-tropic HIV. A tropism assay (typically a genotypic tropism test on HIV RNA from blood) determines which co-receptor your HIV uses. About 80% of HIV-1 worldwide is CCR5-tropic; the proportion of CXCR4-tropic and dual/mixed-tropic virus increases with advanced HIV disease. Without confirmed CCR5-tropic virus, Selzentry should not be started.
Why Isn't Selzentry First-Line For New HIV Diagnoses?
Selzentry is dosed twice daily, requires tropism testing first, has significant drug interactions (CYP3A substrate), and has additional safety concerns (hepatotoxicity boxed warning). Modern INSTI-based first-line regimens (Biktarvy, Triumeq, Dovato) are once-daily single-tablet regimens with simpler dosing and broader applicability. Selzentry is primarily used in treatment-experienced patients with multi-drug resistance who need a non-traditional mechanism.
Are There Drug Interactions I Should Know About?
Yes — maraviroc is a CYP3A substrate, so its dose depends on what else you’re taking. Strong CYP3A inhibitors (most boosted PIs) require dose reduction to 150 mg twice daily. Strong CYP3A inducers (efavirenz, rifampin) require dose increase to 600 mg twice daily. Tell every prescriber and pharmacist about Selzentry.
What About Posture Changes And Selzentry?
Postural (orthostatic) hypotension can occur with Selzentry, especially in patients with renal impairment, on antihypertensives, or with hypotension at baseline. If you feel lightheaded when standing, change positions slowly. Tell your prescriber if symptoms are bothersome.
Can I Get Selzentry Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State ADAP programs may also coordinate with Medicare for HIV-treatment patients.
What If My Application Is Denied?
If denied, we explore alternatives — switching to another HIV regimen appropriate for your resistance profile (Biktarvy, Triumeq, or treatment-experienced combinations with PAP support), state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Selzentry, our team may be able to help you access assistance programs designed to make brand HIV entry inhibitor therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.